PDE5 inhibitors successfully reduce pulmonary arterial and venous vascular tone and enhance penile vasodilation, and are usually used for the treatments of PAH and erectile dysfunction [93]. The gene discussed is PDE5A; the disease is pulmonary arterial hypertension.